Pricing Log in Create free account

Ceryvyn Therapeutics Ltd. - Unsponsored ADR (CYVNY) vs Neurogene Inc. (NGNE)

Ceryvyn Therapeutics Ltd. - Unsponsored ADR and Neurogene Inc. are both Biotechnology companies. Ceryvyn Therapeutics Ltd. - Unsponsored ADR and Neurogene Inc. are of similar size ($533.7M and $524.8M). Neurogene Inc. has the higher net margin (0.00% vs −89,724.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 8 metrics below, Ceryvyn Therapeutics Ltd. - Unsponsored ADR leads on 4 and Neurogene Inc. on 4.

Valuation

Metric CYVNY NGNE Biotechnology median
P/E n/m n/m 10.64
P/S 2.37 n/m 9.59
P/B n/m 2.75 2.15
Price to free cash flow n/m n/m 26.07
EV/EBITDA n/m n/m 0.65
EV/Sales 759.28 n/m 9.45
Earnings yield (2,375.00%) (18.99%) (34.69%)
Free cash flow yield (84,379.36%) (14.68%) (24.02%)

Profitability

Metric CYVNY NGNE Biotechnology median
Gross margin 0.00% 0.00% 65.59%
Operating margin 0.00% 0.00% 0.00%
Net margin (89,724.18%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (45.32%) (51.96%)
Return on assets 0.00% (41.02%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CYVNY NGNE Biotechnology median
Revenue growth (TTM) — — 4.59%
EPS growth (last fiscal year) 61.59% 0.93% 29.88%
Revenue growth, 5-year CAGR (15.81%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CYVNY NGNE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.22 10.64 4.86
Net debt to EBITDA 0.31 2.57 1.01

Dividend

Metric CYVNY NGNE Biotechnology median
Dividend yield — — 0.38%
Payout ratio — — —

Size

Metric CYVNY NGNE Biotechnology median
Market cap 524.83m 533.70m 174.29m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack